Published in Hepatitis Weekly, June 8th, 1998
Researchers from Scotland's University of Glasgow found that many of their patients remained visually impaired long after discontinuing therapy for chronic hepatitis.
"Such visual changes may be present even without any morphologic evidence of retinopathy or anterior ischemic optic neuropathy and although subclinical, are long-lasting and possibly permanent in some cases," Emanuel K. Manesis and colleagues wrote ("Neurovisual Impairment: A Frequent Complication of Alpha-Interferon Treatment in Chronic Viral Hepatitis,"...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.